Decision-making at menopause: a randomized controlled trial of a computer-based hormone therapy decision-aid.

OBJECTIVE Decision-making at menopause remains a challenge for women and their health care providers as the paradigm for hormone therapy continues to evolve. The role of decision-support for this process remains to be defined. METHODS A randomized controlled trial of a computer-based hormone therapy (HT) decision-aid versus a control intervention consisting of a printed pamphlet among 177 post-menopausal women receiving care in a Veterans Affairs Medical Center. RESULTS Participants found the computer-based decision-aid easy to use and retained risk information incorporated from emerging scientific data. There was no difference between groups with respect to the primary outcomes of knowledge, satisfaction with decision, decisional conflict or HT use. A trend was reported towards decreased decisional conflict in the evidence in decision-making (p=0.07) and factors of uncertainty (p=0.06) domains among the subset of participants who were on HT at baseline and used the computer-based decision-aid. CONCLUSION The computer-based decision-aid was able to effectively incorporate emerging scientific information but was no more effective than a printed pamphlet control with regard to improving decision-process outcomes. PRACTICE IMPLICATIONS The incremental benefit of a complex versus simpler decision-aid for post-menopausal women remains to be established prior to widespread dissemination of interactive computer-based HT decision-aids.

[1]  E. Vittinghoff,et al.  Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.

[2]  M. Schapira,et al.  Menopausal hormone therapy decisions: insights from a multi-attribute model. , 2004, Patient education and counseling.

[3]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[4]  Peter Tugwell,et al.  A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy. , 2002, Patient education and counseling.

[5]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[6]  C. McHorney,et al.  Frequency or Probability? A Qualitative Study of Risk Communication Formats Used in Health Care , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  T. Speroff,et al.  A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence , 2004, Annals of Internal Medicine.

[8]  M. Holmes-Rovner,et al.  An educational intervention as decision support for menopausal women. , 1997, Research in nursing & health.

[9]  R. Stafford,et al.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.

[10]  J. Gonyea.  Finished at fifty: the politics of the menopause and hormone replacement therapy. , 1996, American journal of preventive medicine.

[11]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[12]  Ailsa E Gebbie,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.

[13]  B. Rimer,et al.  A tailored intervention to aid decision-making about hormone replacement therapy. , 2002, American journal of public health.

[14]  Deborah Grady,et al.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.

[15]  R. Harvey,et al.  Decision-making preference and opportunity in VA ambulatory care patients: association with patient satisfaction. , 1999, Research in nursing & health.

[16]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[17]  S. Cummings,et al.  Clinical use of bone densitometry: scientific review. , 2002, JAMA.

[18]  M. McNeil,et al.  Patient satisfaction in women’s clinics versus traditional primary care clinics in the veterans administration , 2003, Journal of General Internal Medicine.

[19]  Peter Tugwell,et al.  Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  Stephen B. Hulley,et al.  Noncardiovascular disease outcomes during 6.8 years of hormone therapy : Heart and Estrogen/Progestin Study fellow-up (HERS II) , 2002 .

[21]  M. Holmes-Rovner,et al.  African-American women's attitudes and expectations of menopause. , 1996, American Journal of Preventive Medicine.

[22]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[23]  France Légaré,et al.  The effect of decision aids on the agreement between women's and physicians' decisional conflict about hormone replacement therapy. , 2003, Patient education and counseling.

[24]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[25]  M. Holmes-Rovner,et al.  Patient Satisfaction with Health Care Decisions , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  Aileen Clarke,et al.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process , 2006, BMJ : British Medical Journal.

[27]  Colleen M McBride,et al.  Evaluating participants' use of a hormone replacement therapy decision-making intervention. , 2002, Patient education and counseling.

[28]  A. O'Connor.  Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  A Coulter,et al.  Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care , 2001, BMJ : British Medical Journal.